Sonoma Pharmaceuticals, Inc. (SNOA) stock
SNOANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3081% below fair value
$0.83−0.05 (-5.21%)
Close on Nov 17, 2026Market cap $3.99MP/E –Yield –
Sonoma Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Sonoma Pharmaceuticals's enterprise value was $736.39K on Nov 11, 2026, against $2.51M a year earlier. Over the last 5 years it ranged from -$2.96M to $5.31M, with a median of $532.18K.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $736.39K | -75.7% |
| 2025 | Dec 31, 2025 | $3.03M | – |
| 2024 | Dec 31, 2024 | -$395.13K | – |
| 2023 | Dec 29, 2023 | -$1.20M | -963.1% |
| 2022 | Dec 30, 2022 | $139.34K | -97.4% |
| 2021 | Dec 31, 2021 | $5.31M | -55.2% |
| 2020 | Dec 31, 2020 | $11.86M | +352.6% |
| 2019 | Dec 31, 2019 | $2.62M | +302.2% |
| 2018 | Dec 31, 2018 | $651.54K | -95.2% |
| 2017 | Dec 29, 2017 | $13.67M | -24.2% |
| 2016 | Dec 30, 2016 | $18.02M | +65.3% |
| 2015 | Dec 31, 2015 | $10.90M | +24.8% |
| 2014 | Dec 31, 2014 | $8.74M | -58.4% |
| 2013 | Dec 31, 2013 | $20.99M | +47.3% |
| 2012 | Dec 31, 2012 | $14.25M | -47.5% |
| 2011 | Dec 30, 2011 | $27.13M | – |
See a number that looks wrong?